On 10 August 2018, Japanese Astellas Pharma bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders. Midven’s UK Innovation & Science Seed Fund (UKI2S) was the founding investor with follow-on, co-investment from Cambridge Enterprise. Kenji Yasukawa, Ph.D., President and CEO of […]

read more

Latest news from Midven Accelerating the Midlands Engine Investment Fund Next Investment Readiness workshops — Birmingham Portfolio Company Spotlight: Fertility Focus, Tokamak Energy, i-Nexus Global, Tropic Biosciences & Learning Labs Midven July 2018 Newsletter      

read more

Midven’s CEO Tony Stott shares insights… from real estate to enterprises, there’s just no getting around the need to fix what is broken now in order to attract the right buyers. We’ve been trying to sell two houses over the past 12 months. Both are standard 1990s suburban houses, backing directly onto railway lines and […]

read more

1 2 3 4 5 16
Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now